Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe

The EURIKA study

José R. Banegas, Esther López-García, Jean Dallongeville, Eliseo Guallar, Julian P. Halcox, Claudio Borghi, Elvira L. Massó-González, Francisco J. Jiménez, Joep Perk, Philippe Gabriel Steg, Guy De Backer, Fernando Rodríguez-Artalejo

Research output: Contribution to journalArticle

Abstract

Aims Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to patients at high CVD risk. We assessed the achievement of treatment goals for CVD risk factors among patients with a substantial variation in CVD risk. Methods and resultsThis study was conducted with 7641 outpatients aged 2 (BCR: 12.737.1). About one-third of controlled patients on treatment were still at high remaining CVD risk. Although most patients were advised to reduce excess weight and to follow a low-calorie diet, less than half received written recommendations. Conclusion sIn Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, there is substantial between-country variation, which indicates additional room for improvement. Raised residual CVD risk is relatively frequent among patients despite control of their primary risk factors and should be addressed.

Original languageEnglish (US)
Pages (from-to)2143-2152
Number of pages10
JournalEuropean Heart Journal
Volume32
Issue number17
DOIs
StatePublished - Sep 2011

Fingerprint

Primary Prevention
Cardiovascular Diseases
Therapeutics
Caloric Restriction
Life Style
Counseling
Outpatients
Weights and Measures

Keywords

  • Cardiovascular disease
  • Diabetes
  • Dyslipidaemia
  • Europe
  • Hypertension
  • Obesity
  • Prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Banegas, J. R., López-García, E., Dallongeville, J., Guallar, E., Halcox, J. P., Borghi, C., ... Rodríguez-Artalejo, F. (2011). Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study. European Heart Journal, 32(17), 2143-2152. https://doi.org/10.1093/eurheartj/ehr080

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe : The EURIKA study. / Banegas, José R.; López-García, Esther; Dallongeville, Jean; Guallar, Eliseo; Halcox, Julian P.; Borghi, Claudio; Massó-González, Elvira L.; Jiménez, Francisco J.; Perk, Joep; Steg, Philippe Gabriel; De Backer, Guy; Rodríguez-Artalejo, Fernando.

In: European Heart Journal, Vol. 32, No. 17, 09.2011, p. 2143-2152.

Research output: Contribution to journalArticle

Banegas, JR, López-García, E, Dallongeville, J, Guallar, E, Halcox, JP, Borghi, C, Massó-González, EL, Jiménez, FJ, Perk, J, Steg, PG, De Backer, G & Rodríguez-Artalejo, F 2011, 'Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study', European Heart Journal, vol. 32, no. 17, pp. 2143-2152. https://doi.org/10.1093/eurheartj/ehr080
Banegas, José R. ; López-García, Esther ; Dallongeville, Jean ; Guallar, Eliseo ; Halcox, Julian P. ; Borghi, Claudio ; Massó-González, Elvira L. ; Jiménez, Francisco J. ; Perk, Joep ; Steg, Philippe Gabriel ; De Backer, Guy ; Rodríguez-Artalejo, Fernando. / Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe : The EURIKA study. In: European Heart Journal. 2011 ; Vol. 32, No. 17. pp. 2143-2152.
@article{f687c43a7ee348bea17fce55e68e5f87,
title = "Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study",
abstract = "Aims Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to patients at high CVD risk. We assessed the achievement of treatment goals for CVD risk factors among patients with a substantial variation in CVD risk. Methods and resultsThis study was conducted with 7641 outpatients aged 2 (BCR: 12.737.1). About one-third of controlled patients on treatment were still at high remaining CVD risk. Although most patients were advised to reduce excess weight and to follow a low-calorie diet, less than half received written recommendations. Conclusion sIn Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, there is substantial between-country variation, which indicates additional room for improvement. Raised residual CVD risk is relatively frequent among patients despite control of their primary risk factors and should be addressed.",
keywords = "Cardiovascular disease, Diabetes, Dyslipidaemia, Europe, Hypertension, Obesity, Prevention",
author = "Banegas, {Jos{\'e} R.} and Esther L{\'o}pez-Garc{\'i}a and Jean Dallongeville and Eliseo Guallar and Halcox, {Julian P.} and Claudio Borghi and Mass{\'o}-Gonz{\'a}lez, {Elvira L.} and Jim{\'e}nez, {Francisco J.} and Joep Perk and Steg, {Philippe Gabriel} and {De Backer}, Guy and Fernando Rodr{\'i}guez-Artalejo",
year = "2011",
month = "9",
doi = "10.1093/eurheartj/ehr080",
language = "English (US)",
volume = "32",
pages = "2143--2152",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe

T2 - The EURIKA study

AU - Banegas, José R.

AU - López-García, Esther

AU - Dallongeville, Jean

AU - Guallar, Eliseo

AU - Halcox, Julian P.

AU - Borghi, Claudio

AU - Massó-González, Elvira L.

AU - Jiménez, Francisco J.

AU - Perk, Joep

AU - Steg, Philippe Gabriel

AU - De Backer, Guy

AU - Rodríguez-Artalejo, Fernando

PY - 2011/9

Y1 - 2011/9

N2 - Aims Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to patients at high CVD risk. We assessed the achievement of treatment goals for CVD risk factors among patients with a substantial variation in CVD risk. Methods and resultsThis study was conducted with 7641 outpatients aged 2 (BCR: 12.737.1). About one-third of controlled patients on treatment were still at high remaining CVD risk. Although most patients were advised to reduce excess weight and to follow a low-calorie diet, less than half received written recommendations. Conclusion sIn Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, there is substantial between-country variation, which indicates additional room for improvement. Raised residual CVD risk is relatively frequent among patients despite control of their primary risk factors and should be addressed.

AB - Aims Most studies on the primary prevention of cardiovascular disease (CVD) have been limited to patients at high CVD risk. We assessed the achievement of treatment goals for CVD risk factors among patients with a substantial variation in CVD risk. Methods and resultsThis study was conducted with 7641 outpatients aged 2 (BCR: 12.737.1). About one-third of controlled patients on treatment were still at high remaining CVD risk. Although most patients were advised to reduce excess weight and to follow a low-calorie diet, less than half received written recommendations. Conclusion sIn Europe, a large proportion of patients in primary prevention have CVD risk factors that remain uncontrolled, and lifestyle counselling is not well implemented; moreover, there is substantial between-country variation, which indicates additional room for improvement. Raised residual CVD risk is relatively frequent among patients despite control of their primary risk factors and should be addressed.

KW - Cardiovascular disease

KW - Diabetes

KW - Dyslipidaemia

KW - Europe

KW - Hypertension

KW - Obesity

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=80052492899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052492899&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehr080

DO - 10.1093/eurheartj/ehr080

M3 - Article

VL - 32

SP - 2143

EP - 2152

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 17

ER -